Ajanta Pharma Buyback 2023 vs Welspun India Buyback 2023

Comparison between Ajanta Pharma Buyback 2023 and Welspun India Buyback 2023.

Buyback Details

Ajanta Pharma Buyback 2023 is a Tender Offer buyback proposed to list at BSE, NSE while Welspun India Buyback 2023 is a Tender Offer proposed to list at BSE, NSE.

 Ajanta Pharma Ltd.Welspun India Ltd.
LogoAjanta Pharma Buyback 2023 LogoWelspun India Buyback 2023 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹2 per share₹1 per share
Buyback Price₹1425 per share₹120 per share
Issue Size22,10,500 shares1,62,50,000 shares
Issue Size (Amount)₹315.00 Crores₹195.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders20 Equity Shares out of every 99 Fully paid-up Equity Shares held on the Record Date.331,575.00
General Category for all other Eligible Shareholders3 Equity Shares out of every 202 Fully paid-up Equity Shares held on the Record Date.1,878,925.00
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders5 Equity Shares out of every 81 Fully paid-up Equity Shares held on the Record Date.2,437,500.00
General Category for all other Eligible Shareholders1 Equity Shares out of every 69 Fully paid-up Equity Shares held on the Record Date.13,812,500.00
RegistrarMUFG Intime India Pvt.Ltd.MUFG Intime India Pvt.Ltd.
Lead ManagersEdelweiss Financial Services Ltd.Dam Capital Advisors Ltd.
Necessity of the buyback

The buyback is being undertaken for the following reasons:

  1. The buyback will help the company to return surplus cash to its equity shareholders broadly in proportion to their shareholding, thereby enhancing the overall return to shareholders.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit a large number of public shareholders who would get classified as "small shareholders".
  3. The buyback may help in improving return on equity, reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.
  5. The buyback may lead to a reduction in outstanding Equity Shares, an improvement in earnings per equity share, and an enhanced return on equity.

The Buy-back is being undertaken for the following reasons:

  1. The Buy-back will help the Company to return surplus cash to its members, holding equity shares, in proportion to their shareholding.
  2. The Buy-back includes a reservation for the small shareholders. The Company believes that this reservation for small shareholders would benefit a large number of public shareholders, who would get classified as "small shareholders".
  3. The Buy-back may help in improving return on equity, by reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buy-back gives an option to the members holding equity shares of the Company, who can choose to participate and get cash in lieu of equity shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buy-back.

Buyback Timetable

Ajanta Pharma Buyback 2023 and Welspun India Buyback 2023 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback 2023 Buyback record date is Mar 24, 2023. Welspun India Buyback 2023 Buyback record date is May 10, 2023.

 Ajanta Pharma Ltd.Welspun India Ltd.
Record DateMar 24, 2023May 10, 2023
Offer Open DateMar 31, 2023May 16, 2023
Offer Closure DateApr 10, 2023May 22, 2023
Last date for receipt of tender formsApr 10, 2023May 22, 2023
Finalisation of buybackApr 13, 2023May 26, 2023
Last Date for settlment of bidsApr 18, 2023May 29, 2023
Last Date for extinguishment of sharesApr 27, 2023Jun 07, 2023

Financial Details and Other Relevent Information

Comparison of Ajanta Pharma Buyback 2023 and Welspun India Buyback 2023 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Ajanta Pharma Ltd.Welspun India Ltd.
Financial
Ajanta Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-202,680.06467.70
31-Mar-213,778.722,915.67653.87
31-Mar-224,055.583,456.67712.68
Amount in ₹ Crore
Welspun India Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-197,742.286,608.44226.182,779.302,623.551,908.43
31-Mar-208,310.286,836.18524.362,972.102,972.501,684.85
31-Mar-218,677.787,407.95550.793,644.703,516.391,096.19
31-Mar-229,436.859,377.31606.703,971.703,862.031,214.18
31-Mar-238,650.0082,151.00202.5140,878.003,974.85
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1252.00 4523.00 1197.49
Jan-2023 1222.90 3168.00 1186.12
Dec-2022 1272.00 1192.00 1210.90

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2023 70.37 62.20 66.47
Feb-2023 73.00 63.60 68.96
Jan-2023 77.65 65.25 72.25
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1254.00 1151.35 1198.12
Jan-2023 1224.00 1150.00 1186.49
Dec-2022 1266.25 1150.25 1210.19

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2023 70.40 62.00 66.50
Feb-2023 71.85 63.50 69.00
Jan-2023 77.70 66.25 72.29

Compare with others

Compare:

Ajanta Pharma Buyback 2023 and Welspun India Buyback 2023